You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Correction: Nemvaleukin Alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Nemvaleukin Alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to July 2025

AbstractFullPdf
Nov 2022019929
Dec 20220699
Jan 20230371
Feb 20230395
Mar 2023080
Apr 20230122
May 20230105
Jun 2023092
Jul 20230106
Aug 2023062
Sep 2023055
Oct 2023054
Nov 20230111
Dec 2023094
Jan 20240146
Feb 2024095
Mar 202401617
Apr 20240146
May 20240118
Jun 20240163
Jul 20240175
Aug 2024094
Sep 20240103
Oct 20240137
Nov 2024095
Dec 20240115
Jan 2025083
Feb 2025032
Mar 2025086
Apr 20250183
May 2025033
Jun 20250133
Jul 2025010
Total0632169